HPV9-valent recombinant vaccine (types 6,11,16,18,31,33,45,52,58)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for HPV9-valent recombinant vaccine (types 6,11,16,18,31,33,45,52,58), covering 2025-07-31 to 2025-07-31. Get the full timeline:
Most recent: Clinical Trial Update: A Phase III Trial to Evaluate the Efficacy, Immunogenicity and Safety of a Recombinant Human Papillomavirus 9-Valent (Types 6, 11, 16, 18, 31, 33, 45, 52, 58) Vaccine (E.Coli) in Chinese Males [Phase 3]